Status:
COMPLETED
Effectiveness Study of Short Course of Magnesium Sulfate for Severe Preeclamsia
Lead Sponsor:
Instituto Materno Infantil Prof. Fernando Figueira
Conditions:
Severe Preeclampsia
Eligibility:
FEMALE
11-50 years
Phase:
PHASE4
Brief Summary
Magnesium sulfate is the ideal drug for seizures prophilaxis in preeclampsia. The ideal duration of this treatment after delivery is still to be established. The hypothesis is that in stable patients ...
Detailed Description
Magnesium sulfate (MgSO4) is certainly the ideal drug for prevention and control of eclamptic seizures. However, there is no consensus on the appropriate duration of prophylaxis with this anticonvulsa...
Eligibility Criteria
Inclusion
- Pre-eclampsia;
- Puerperium.
Exclusion
- Associated maternal diseases;
- Use of illicit drugs or other medications that might interfere with maternal hemodynamics;
- Contraindications to the use of magnesium sulfate: drug hypersensitivity, oliguria with urine output below 25ml/h; anuria (absent urine output), myasthenia gravis.
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01408979
Start Date
August 1 2011
End Date
February 1 2012
Last Update
August 22 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IMIP
Recife, Pernambuco, Brazil, 50.000